Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
700 A phase II trial of MOnaliZumab plus durvAlumab plus platinum-based chemotheRapy for first-line treatment of extensive stage small cell lung cancer (MOZART): A Hoosier Cancer Research Network study
Compose a Response to This Article
Other responses
No responses have been published for this article.
